Choong Ang Vaccine Laboratory operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Choong Ang Vaccine Laboratory with three other
companies in this sector in South Korea:
Komipharm International Company Limited
sales of 34.99 billion Korean Won [US$29.50 million]
of which 96%
was Finished Goods),
Eu Biologics Co Ltd
(24.89 billion Korean Won [US$20.98 million]
of which 91%
was OCV), and
(22.32 billion Korean Won [US$18.81 million]
of which 87%
was The clinical trial agent).
During the year ended December of 2018, sales at
Choong Ang Vaccine Laboratory were 33.15 billion Korean Won (US$27.95 million).
increase of 4.0%
versus 2017, when the company's sales were 31.87 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2016, when Choong Ang Vaccine Laboratory
reported sales of 37.90 billion Korean Won.